BioCentury | Sep 8, 2020
Management Tracks

Black Diamond names Humphrey CMO; plus Edmondson to lead chemistry at Nimbus, Recce, Amarna and more

...pathology at the Icahn School of Medicine at Mount Sinai. David Pomerantz joined real-world evidence company Syapse Inc....
BioCentury | Oct 18, 2019
Company News

Management tracks: Sirtex makes interim CEO permanent; plus Magenta, Pyxis, Stoke, Cadent, StemoniX, Enzyvant, Syapse and Stalicla

...Jeb Ledell as COO. He was COO at Compass Therapeutics LLC. Precision cancer therapy play Syapse Inc....
...with which Stalicla is collaborating. Jonathan Block, Associate Editor Enzyvant Sciences GmbH Stoke Therapeutics Inc. Sirtex Medical Ltd. Magenta Therapeutics Inc. Syapse Inc. Cadent...
BioCentury | Sep 12, 2019
Company News

Management tracks: Vifor, Kintai, Verge, Xellia, Syapse

...Pharmaceuticals promoted the national accounts lead for the North America branch Peter Baker to CCO. Syapse Inc....
...medicine data company from Catalyst Biosciences Inc. (NASDAQ:CBIO), where he was CFO since January 2015. BC Staff Vifor Kintai Verge Xellia Syapse...
BioCentury | Aug 14, 2019
Company News

FDA, Syapse partner to generate real-world evidence from more sources

...FDA announced a multiyear collaboration with Syapse that will help the agency expand its real-world data...
...allow comparisons across patients that generate actionable insights, something Syapse and other companies are tackling. Syapse...
...mutations. Syapse's platform helps track patients' genomic profiles, treatment histories and clinical outcomes. Allison Johnson, Senior Writer AACR Syapse Inc. U.S...
BioCentury | Jul 24, 2019
Company News

July 23 Company Quick Takes: FDA approves Pfizer’s Rituxan biosimilar; plus Intra-Cellular, OTC Tamiflu, Cimzia and more

...partnered with precision medicine company Syapse Inc. (San Francisco, Calif.) to use real-world evidence derived from Syapse’s...
...CDP 870) lumateperone (ITI-007) Tamiflu, oseltamivir (GS 4104, Ro 64-0796) Exscientia Ltd. Genentech Inc. Intra-Cellular Therapies Inc. Iveric bio Inc. Pfizer Inc. Rallybio LLC Roche Sanofi Syapse Inc. UCB...
BioCentury | May 2, 2019
Company News

May 2 Company Quick Takes: Agios, Celgene/Presage, Purdue, Amgen/Syapse

...NYSE:JNJ), Noramco Inc., Teva Pharmaceutical Industries Ltd. (NYSE:TEVA; Tel Aviv:TEVA) and Allergan plc (NYSE:AGN). Amgen, Syapse...
...identify patients for clinical trials of its cancer candidates through a health network assembled by Syapse Inc....
...disclosed. Mark Zipkin, Staff Writer Tibsovo, ivosidenib (AG-120, CS3010, IDH1 inhibitor) Agios Pharmaceuticals Inc. Amgen Inc. Celgene Corp. Presage Biosciences Purdue Pharma L.P. Syapse Inc....
BioCentury | Sep 1, 2018
Politics, Policy & Law

Back to School 2018: A pathway to Biopharma 3.0

...its January partnership with Syapse Inc. and the pharma’s February acquisition of Flatiron Health Inc. Through Syapse...
...Analytics Inc., San Mateo, Calif. Roche (SIX:ROG; OTCQX:RHHBY), Basel, Switzerland Sanofi (Euronext:SAN; NYSE:SNY), Paris, France Syapse Inc....
BioCentury | Jun 22, 2018
Company News

Roche taps gRED’s Sabry as global head of partnering

...from GNS Healthcare Inc. (Cambridge, Mass.) to develop cancer therapies. In January, Roche partnered with Syapse...
BioCentury | Mar 9, 2018
Strategy

Accelerating Flatiron

...disease drivers in oncology that can help identify responder populations. In January, Roche partnered with Syapse Inc....
...healthcare systems and develop software products and analytics Syapse can use across its network. The Syapse...
...of technologies to analyze cancer data. Flatiron’s data set is most complementary to that of Syapse Inc....
BioCentury | Mar 8, 2018
Finance

Intelligent diligence

...round, and is acquiring the remaining 87% for $1.9 billion. In January, Roche partnered with Syapse Inc....
...financial terms on par with those of traditional therapeutic deals, according to Talbert. In the Syapse...
...Electric Co. (NYSE:GE), Fairfield, Conn. GNS Healthcare Inc., Cambridge, Mass. Roche (SIX:ROG; OTCQX:RHHBY), Basel, Switzerland Syapse Inc....
Items per page:
1 - 10 of 17
BioCentury | Sep 8, 2020
Management Tracks

Black Diamond names Humphrey CMO; plus Edmondson to lead chemistry at Nimbus, Recce, Amarna and more

...pathology at the Icahn School of Medicine at Mount Sinai. David Pomerantz joined real-world evidence company Syapse Inc....
BioCentury | Oct 18, 2019
Company News

Management tracks: Sirtex makes interim CEO permanent; plus Magenta, Pyxis, Stoke, Cadent, StemoniX, Enzyvant, Syapse and Stalicla

...Jeb Ledell as COO. He was COO at Compass Therapeutics LLC. Precision cancer therapy play Syapse Inc....
...with which Stalicla is collaborating. Jonathan Block, Associate Editor Enzyvant Sciences GmbH Stoke Therapeutics Inc. Sirtex Medical Ltd. Magenta Therapeutics Inc. Syapse Inc. Cadent...
BioCentury | Sep 12, 2019
Company News

Management tracks: Vifor, Kintai, Verge, Xellia, Syapse

...Pharmaceuticals promoted the national accounts lead for the North America branch Peter Baker to CCO. Syapse Inc....
...medicine data company from Catalyst Biosciences Inc. (NASDAQ:CBIO), where he was CFO since January 2015. BC Staff Vifor Kintai Verge Xellia Syapse...
BioCentury | Aug 14, 2019
Company News

FDA, Syapse partner to generate real-world evidence from more sources

...FDA announced a multiyear collaboration with Syapse that will help the agency expand its real-world data...
...allow comparisons across patients that generate actionable insights, something Syapse and other companies are tackling. Syapse...
...mutations. Syapse's platform helps track patients' genomic profiles, treatment histories and clinical outcomes. Allison Johnson, Senior Writer AACR Syapse Inc. U.S...
BioCentury | Jul 24, 2019
Company News

July 23 Company Quick Takes: FDA approves Pfizer’s Rituxan biosimilar; plus Intra-Cellular, OTC Tamiflu, Cimzia and more

...partnered with precision medicine company Syapse Inc. (San Francisco, Calif.) to use real-world evidence derived from Syapse’s...
...CDP 870) lumateperone (ITI-007) Tamiflu, oseltamivir (GS 4104, Ro 64-0796) Exscientia Ltd. Genentech Inc. Intra-Cellular Therapies Inc. Iveric bio Inc. Pfizer Inc. Rallybio LLC Roche Sanofi Syapse Inc. UCB...
BioCentury | May 2, 2019
Company News

May 2 Company Quick Takes: Agios, Celgene/Presage, Purdue, Amgen/Syapse

...NYSE:JNJ), Noramco Inc., Teva Pharmaceutical Industries Ltd. (NYSE:TEVA; Tel Aviv:TEVA) and Allergan plc (NYSE:AGN). Amgen, Syapse...
...identify patients for clinical trials of its cancer candidates through a health network assembled by Syapse Inc....
...disclosed. Mark Zipkin, Staff Writer Tibsovo, ivosidenib (AG-120, CS3010, IDH1 inhibitor) Agios Pharmaceuticals Inc. Amgen Inc. Celgene Corp. Presage Biosciences Purdue Pharma L.P. Syapse Inc....
BioCentury | Sep 1, 2018
Politics, Policy & Law

Back to School 2018: A pathway to Biopharma 3.0

...its January partnership with Syapse Inc. and the pharma’s February acquisition of Flatiron Health Inc. Through Syapse...
...Analytics Inc., San Mateo, Calif. Roche (SIX:ROG; OTCQX:RHHBY), Basel, Switzerland Sanofi (Euronext:SAN; NYSE:SNY), Paris, France Syapse Inc....
BioCentury | Jun 22, 2018
Company News

Roche taps gRED’s Sabry as global head of partnering

...from GNS Healthcare Inc. (Cambridge, Mass.) to develop cancer therapies. In January, Roche partnered with Syapse...
BioCentury | Mar 9, 2018
Strategy

Accelerating Flatiron

...disease drivers in oncology that can help identify responder populations. In January, Roche partnered with Syapse Inc....
...healthcare systems and develop software products and analytics Syapse can use across its network. The Syapse...
...of technologies to analyze cancer data. Flatiron’s data set is most complementary to that of Syapse Inc....
BioCentury | Mar 8, 2018
Finance

Intelligent diligence

...round, and is acquiring the remaining 87% for $1.9 billion. In January, Roche partnered with Syapse Inc....
...financial terms on par with those of traditional therapeutic deals, according to Talbert. In the Syapse...
...Electric Co. (NYSE:GE), Fairfield, Conn. GNS Healthcare Inc., Cambridge, Mass. Roche (SIX:ROG; OTCQX:RHHBY), Basel, Switzerland Syapse Inc....
Items per page:
1 - 10 of 17